Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen Buys Rights to Acorda’s MS Pill Outside U.S.
Biogen Buys Rights to Acorda’s MS Pill Outside U.S.
Biogen Buys Rights to Acorda’s MS Pill Outside U.S.
Submitted by
admin
on July 1, 2009 - 9:04am
Source:
Bloomberg
News Tags:
Biogen Idec
Acorda Therapeutics
Fampridine-SR
MS
Headline:
Biogen Buys Rights to Acorda’s MS Pill Outside U.S.
Do Not Allow Advertisers to Use My Personal information
